Paper Details 
Original Abstract of the Article :
Evidence from placebo-controlled, randomized clinical trials supports the use of chemoprevention in women at high risk for developing breast cancer, and two agents-tamoxifen and raloxifene-are U.S. Food and Drug Administration (FDA)-approved for the indication. Despite clinical guidelines that recom...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.14694/EdBook_AM.2012.32.152

データ提供:米国国立医学図書館(NLM)

Chemoprevention for Breast Cancer: Overcoming Barriers to Treatment

Breast cancer, like a looming sandstorm on the horizon, is a serious threat. This study discusses chemoprevention, a proactive approach to reducing breast cancer risk, like building a sand-resistant barrier against the storm.

Increasing Chemoprevention Uptake

Despite the effectiveness of chemoprevention, its uptake has been low, like a well-built barrier left unused. This study highlights the barriers, such as fear of side effects and lack of patient knowledge, and outlines strategies to increase its utilization, like strengthening and promoting the use of the barrier.

Empowering Patients with Information

This research emphasizes the importance of empowering patients with knowledge and providing them with access to resources. It's like equipping desert travelers with maps and survival guides, ensuring they have the information needed to navigate the journey.

Dr.Camel's Conclusion

This study is a call to action to improve awareness and access to chemoprevention for high-risk individuals. It's like spreading the word about the importance of a protective barrier, ensuring that those most at risk are prepared for the sandstorm.

Date :
  1. Date Completed 2016-04-15
  2. Date Revised 2020-02-10
Further Info :

Pubmed ID

24451714

DOI: Digital Object Identifier

10.14694/EdBook_AM.2012.32.152

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.